photo walkheader_zpsd5bunpmi.png

Category Archives: Pancreatic Cancer Medical Treatment

2016 ASCO Practice Guidelines for Advanced Pancreatic Cancer

2016 ASCO PRACTICE GUIDELINES FOR ADVANCED ADENOCARCINOMA OF THE PANCREAS Davendra P.S. Sohal, Pamela B. Mangu, Alok A. Khorana, Manish A. Shah, Philip A. Philip, Eileen M. O’Reilly, Hope E. Uronis, Ramesh K. Ramanathan, Christopher H. Crane, Anitra Engebretson, Joseph T. Ruggiero, Mehmet S. Copur, Michelle Lau, Susan Urba and Daniel Laheru   Abstract Purpose: […]

“Modified” FOLFIRINOX Regimen Approved by FDA for 2nd Line Treatment of Pancreatic Cancer

On the 22nd of October, 2015, the U.S. Food and Drug Administration approved a new combination therapy that includes the drug Onivyde for patients with metastatic pancreatic cancer (ductal adenocarcinoma of the pancreas) who had earlier been treated until progression of disease while on gemcitabine or a gemcitabine-based regimen. Onivyde is liposomal irinotecan, a topoisomerase I […]

Clinical trial of Combination of Targeted Anti-Kras Therapy for Pancreatic Cancer

Dutch and primarily other European researchers are about to begin a human clinical trial involving a regimen of two relatively new targeted therapies (afatinib plus selumetinib) for the treatment of pancreatic cancer (ductal adenocarcinoma of the pancreas).  Afatinib is known as Gilotrif in the U.S., and is produced by the family-owned global but German-headquartered Boehringer […]

Page 4 of 11« First...23456...10...Last »
Facebook
Facebook